Book Review: Reconstruction, Replication, and Re-enactment in the Humanities and Social Sciences by Peter Inker

Get full text

Event Review: Biannual Conference of the Association of European Open Air Museums (AEOM), Poland, August 2019 by Peter Inker

Get full text

Colonial Williamsburg: Archaeology, Interpretation and Phenomenology by Peter Inker

Get full text

Keynote Closing Address for EAC12: The Worldwide State of Experimental Archaeology and the Agenda for the Future by Linda Hurcombe, Peter Inker

“…Linda Hurcombe and Peter Inker gave the closing talk at EAC12 amazing conference. …”
Get full text

A Sámi media system? by Rasmussen Torkel, Sara Inker-Anni, Krøvel Roy

Get full text

Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trial... by Willem Collier, Benjamin Haaland, Lesley A. Inker, Hiddo J.L. Heerspink, Tom Greene

Get full text

Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease by Vonesh, E, Tighiouart, H, Ying, J, Heerspink, HL, Lewis, J, Staplin, N, Inker, L, Greene, T

Cystatin C as a GFR Estimation Marker in Acute and Chronic Illness: A Systematic Review by Ogechi M. Adingwupu, Ernesto Rodolpho Barbosa, Paul M. Palevsky, Joseph A. Vassalotti, Andrew S. Levey, Lesley A. Inker

Get full text

Long‐Term Changes in Estimated Glomerular Filtration Rate in Left Ventricular Assist Device Recipients: A Longitudinal Joint Model Analysis by Bethany Roehm, Susan Hedayati, Amanda R. Vest, Gaurav Gulati, Jonathan Miao, Hocine Tighiouart, Daniel E. Weiner, Lesley A. Inker

Get full text

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation by Yunwen Xu, Alex R. Chang, Lesley A. Inker, Mara McAdams‐DeMarco, Morgan E. Grams, Jung‐Im Shin

Get full text

Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial by Simke W. Waijer, Di Xie, Silvio E. Inzucchi, Bernard Zinman, Audrey Koitka‐Weber, Michaela Mattheus, Maximillian von Eynatten, Lesley A. Inker, Christoph Wanner, Hiddo J. L. Heerspink

Get full text

Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR: Interpretation According to Performance Compared to Measured GFRPlain-Language Summary by Yeli Wang, Ogechi M. Adingwupu, Michael G. Shlipak, Alessandro Doria, Michelle M. Estrella, Marc Froissart, Vilmundur Gudnason, Anders Grubb, Roberto Kalil, Michael Mauer, Peter Rossing, Jesse Seegmiller, Josef Coresh, Andrew S. Levey, Lesley A. Inker

Get full text

Serum Uromodulin and All-Cause Mortality in Peritoneal Dialysis Patients: A Chinese Cohort Study by Dominik Steubl, MD, Li Fan, MD, PhD, Yunfang Zhang, MD, PhD, Fei Xiong, MD, PhD, Hongbo Li, MD, Hao Zhang, MD, PhD, Jing Hu, MD, PhD, Amy B. Karger, PhD, Lesley A. Inker, MD, MS, Xueqing Yu, MD, PhD, Andrew S. Levey, MD

Get full text

Relationship of eGFR and Albuminuria to concurrent laboratory abnormalities: An individual participant data meta-analysis in a global consortium by Inker, L, Grams, M, Levey, A, Coresh, J, Cirillo, M, Collins, J, Gansevoort, R, Gutierrez, O, Hamano, T, Heine, G, Ishikawa, S, Jee, S, Kronenberg, F, Landray, M, Miura, K, Nadkarni, G, Peralta, C, Rothenbacher, D, Schaeffner, E, Sedaghat, S, Shlipak, M, Zhang, L, van Zuilen, A, Hallan, S, Kovesdy, C, Woodward, M, Levin, A

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure by Inker, LA, Collier, W, Greene, T, Miao, S, Chaudhari, J, Appel, GB, Badve, SV, Caravaca-Fontán, F, Del Vecchio, L, Floege, J, Goicoechea, M, Haaland, B, Herrington, WG, Imai, E, Jafar, TH, Lewis, JB, Li, PKT, Maes, BD, Neuen, BL, Perrone, RD, Remuzzi, G, Schena, FP, Wanner, C, Wetzels, JFM, Woodward, M, Heerspink, HJL

Global burden of cardiovascular diseases and risk factors, 1990–2019 by Roth, GA, Roth, GA, Mensah, GA, Johnson, CO, Addolorato, G, Ammirati, E, Baddour, LM, Barengo, NC, Beaton, AZ, Benjamin, EJ, Benziger, CP, Bonny, A, Brauer, M, Brodmann, M, Cahill, TJ, Carapetis, J, Catapano, AL, Chugh, SS, Cooper, LT, Coresh, J, Criqui, M, DeCleene, N, Eagle, KA, Emmons-Bell, S, Feigin, VL, Fernández-Solà, J, Fowkes, G, Gakidou, E, Grundy, SM, He, FJ, Howard, G, Hu, F, Inker, L, Karthikeyan, G, Kassebaum, N, Koroshetz, W, Lavie, C, Lloyd-Jones, D, Lu, HS, Mirijello, A, Temesgen, AM, Mokdad, A, Moran, AE, Muntner, P, Narula, J, Neal, B, Ntsekhe, M, Moraes de Oliveira, G, Otto, C, Lacey, B, GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group

The 46.1 Antibody Mediates Neurotensin Uptake into the CNS and the Effects Depend on the Route of Intravenous Administration by Julia V. Georgieva, Moriah Katt, Zhou Ye, Benjamin J. Umlauf, Cody J. Wenthur, Eric V. Shusta

“…To further characterize the brain targeting and penetrating properties of clone 46.1, we conjugated neurotensin (NT) to an scFv-Fc form of the antibody (46.1-scFv-Fc-<b>L</b>ong<b>L</b>inker-NT). While centrally administered NT decreases the core body temperature and locomotor activity, effects attributed to two spatially segregated brain areas, systemically administered NT has limited effects. …”
Get full text